The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCBUY.L Regulatory News (CBUY)

  • There is currently no data for CBUY

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Unaudited Interim Results

12 Aug 2009 07:00

RNS Number : 2845X
@UK PLC
12 August 2009
 



Under embargo until 7:00am

12 August 2009

@UK PLC

("@UK" or the "Company")

Unaudited Interim Results for the six months ended 30 June 2009

@UK PLC (AIM:ATUK.L), a provider of spend analysis, eCommerce and eProcurement software solutions that combine into a comprehensive eMarketplace used by government, health and private sectors, today announces its unaudited interim results for the six months ended 30 June 2009.

Highlights:

Revenue up from £1,078,000 to £1,226,000 - a 14% increase

Costs reduced from £1,396,000  to £ 1,340,000  - a 4% reduction

Adjusted loss before tax down from £593,000 to £415,000 - a 30% reduction

Gross Margin up from 72% to 75%

Placing of new shares raising £198,000 after expenses 

Period end cash £ 413,000  (31 December 2008: £553,000 )

Announcement of new initiative with Barclaycard Commercial

Commenting on the results, Ronald Duncan, Chairman said:

"2009 has started to deliver some of the long promised results for @UK and with its strategy and business structure in place this can continue. Based on the achievements so far this year the Board is confident in @UK's future."

For further information please contact:

@UK PLC

Ronald Duncan

+44 (0) 118 963 7000

Beaumont Cornish Limited 

Roland Cornish

+44 (0) 20 7628 3396

Notes to Editors

@UK PLC is a leading UK electronic marketplace provider, that has formed over 180,000 companies using its SiteGenerator ecommerce engine and is providing ecommerce to NHS Suppliers as part of NHS Cat with NHS Supply Chain. @UK PLC's SiteGenerator ecommerce allows suppliers to trade with all major finance systems, @UK PLC's marketplace and other leading marketplaces.

@UK PLC has an OGC Buying Solutions framework contract for the provision of its new Spend Analysis services.

@UK's software provides a secure internet eMarketplace enabling buyers such as local authorities, schools and hospitals to buy online from commercial suppliers ranging from large corporations to small to medium enterprises (SMEs). This allows buying and selling to take place with no paperwork and transposition reduced chance of errors, achieving major savings throughout the supply chain. @UK PLC also offers services to new businesses, including incorporation, company secretarial services and filing annual returns.

@UK is included in the Software and Computer Services Sector (9530). For further information please visit www.uk-plc.net.

CHAIRMAN'S STATEMENT

Summary

2009 has started to deliver some of the long promised results for @UK and with its strategy and business structure in place this can continue.

Financial results 

Revenue for the six months to 30 June 2009 increased 14% to £1,226,000 (2008: £1,078,000), reflecting the commencement of our Spend Analysis service

The operating loss was £460,000 (2008: £706,000). After net interest income of £3,000 (2008: £32,000), the loss before tax was £457,000, compared to £674,000 in 2008. During the six months our cash reduced by £140,000 to £413,000 (2008reduction of £602,000). The loss before tax and cash outflow from operating activities in the first half were both substantially reduced from the levels in the second half of 2008by 46% and 49% respectively, as the benefits of cost reductions flowed through.  

Operational and Performance Review

My primary focus over the last 6 months has been to create a lean & effective company with a clear strategic direction. I wanted to ensure that everyone at @UK plc knows what they have to do to deliver for our customers. This focus is now starting to deliver results.

 

We believe we have a great software solution but have been hampered in realising our potential by, we believe, negative customer perception of marketplace solutions generally, many of which are sunset products. Working closely with our target customers, our Business Development Team has been changing this perception. We have been assisted in this by the ease of use and reliability of our systems, which have exceeded our SLA levels in the first half year, with no recorded downtime on our front end web servers.

In the NHS we have been focusing on implementations through to e-invoicing at a number of NHS Trusts across the UK. We can then build on these implementations through the Channel Marketing strategy, where we are starting to see the benefits of the Barclaycard/@UK joint product launch and NHS Supply Chain joint promotional activity.

In the period we also showcased our solutions at National Social Service Conferences. The boundary between Health and Local Government is changing as NHS Primary Care Trusts and Local Authorities increase their collaboration. Our work in Social Services and our positioning as the only leading marketplace in these two sectors leaves us well placed to take advantage of these changes and to support the move to Patient Centric Budgets. Because of our work in the NHS and our inclusion within the NHS secure network (N3) we can hold patient data, equally with our banking relationships we can provide facilities for the secure and controlled management of patients budgets across different agencies.

Our R&D Team has continued to enhance SpendInsightour Spend Analysis solution. SpendInsight provides detailed product item information through a fully automated Artificial Intelligence engine. This significantly reduces the cost and time to produce the information, differentiating our solution in the market. As one of only 8 suppliers on the OGC Buying Solutions Framework and with The London Procurement Programme as our launch customer this product is already proving a example of @UK's ability to design, develop and deliver innovation.

Company Formations

The overall company formation market was down in the first half, with 4% fewer companies incorporated than in the same period last yearGiven this, we believe the 2% fall in revenues in our Company Formation business was a commendable result. It was helped by the fact that a significant proportion of our revenues come from associated services such as registered office.  There are signs that the fall in the overall market has ended with small year on year increases in the number of companies formed in May and June. We are working on a new website for our Company Formations Business to improve its marketing.

Strategy 

Our strategy now is to focus on our core technical strength and to use channel partners to take our products to market. NHS Supply Chain and Barclaycard Commercial provide us with a strong foundation from which we can build. 

Since @UK was set up, in aggregate over 900,000 log-ins have been created by users of the system. In the medium term we will look to find ways of generating additional revenue from this user base.

Share issue

When releasing our 2008 results in April we announced the Board's intention to raise £150,000 through a placing of new ordinary shares to provide additional working capital for the company. This fundraising was completed with the issue of 15,000,000 shares at 1p. Following announcement of that placing the Board received some further expressions of interest in subscribing for new shares so a further £50,000 was raised in May through the issue of 5,000,000 ordinary shares at 1p. It was very pleasing that our issue was well supported and that we ended up raising double the amount that we indicated in our February trading statement.

People

This year has continued to be one of change in terms of structure and personnel and I am now confident we have the right team in place to deliver results. To reward the teams' performance we are introducing incentives by means of share options and profit share.  On behalf of the Board I would like to formally thank all our employees for their hard work and effort during the year so far. 

Outlook

Based on the achievements so far this year the Board is confident in @UK's future.

Ronald Duncan

Executive Chairman

12 August 2009

 

CONSOLIDATED INCOME STATEMENT (UNAUDITED)

Notes

months to

30 June

2009

£'000

months to

30 June

2008

£'000

Year ended

31 Dec

2008

£'000

Revenue

2

1,226

1,078

2,172

Cost of sales

(304)

(307)

(643)

Gross profit

922

771

1,529

Administrative expenses

(1,340)

(1,396)

(2,869)

Share based payments

11

(14)

13

Operating loss before exceptional item

(407)

(639)

(1,327)

Exceptional items

3

(53)

(67)

(228)

Operating loss

(460)

(706)

(1,555)

Investment income

6

34

41

Finance costs

(3)

(2)

(8)

Loss on ordinary activities before taxation

(457)

(674)

(1,522)

Taxation

-

-

181

Loss for the year attributable to equity shareholders of the parent

(457)

(674)

(1,341)

Loss per share - basic and diluted

4

1.0

1.8

3.5

Revenue and operating loss all derive from continuing operations.

 

CONSOLIDATED BALANCE SHEET (UNAUDITED)

30 June

2009

£'000

30 June

2008

£'000

31 Dec

2008

£'000

Assets

Non-current assets

Goodwill

-

96

­-

Other intangible assets

6

32

17

Property, plant and equipment

137

374

229

143

502

246

Current assets

Trade and other receivables

508

330

535

Cash and cash equivalents

413

1,189

553

921

1,519

1,088

Total assets

1,064

2,021

1,334

Liabilities

Current liabilities

Trade and other payables

(546)

(526)

(541)

Income tax

-

(3)

-

Financial liabilities - borrowings

(12)

(12)

(12)

(558)

(541)

(553)

Non-current liabilities

Financial liabilities - borrowings

(37)

(48)

(42)

(37)

(48)

(42)

Total liabilities

(595)

(589)

(595)

Net assets

469

1,432

739

Shareholders' equity

Called up share capital

578

378

378

Share premium

10,112

10,114

10,114

Other reserve

630

630

630

Share based payment reserve

54

91

65

Accumulated losses

(10,905)

(9,781)

(10,448)

Total equity attributable to equity shareholders of the parent

469

1,432

739

   CONSOLIDATED CASH FLOW STATEMENT (UNAUDITED)

months to

30 June

2009

£'000

months to

30 June

2008

£'000 

Year ended

31 Dec

2008

£'000 

Cash flows from operating activities

Loss for the period

(457)

(674)

(1,522)

Adjustments for:

Finance income (net)

(3)

(32)

(33)

Depreciation of property, plant & equipment

106

132

254

Amortisation of other intangible assets

11

15

30

Share based payments

(11)

14

(13)

Goodwill impairment provision

-

-

96

Loss on disposal of fixed assets

-

-

25

Changes in working capital

Trade and other receivables

(101)

(18)

(45)

Trade and other payables

5

(60)

(45)

Net cash used by operations

(450)

(623)

(1,253)

Tax repayment

128

-

-

Net cash outflow from operating activities

(322)

(623)

(1,253)

Cash flows from investing activities

Interest received

6

34

41

Interest paid

(3)

(2)

(8)

Purchase of property, plant and equipment

(14)

(4)

(7)

Proceeds from sale of property, plant and equipment

-

-

2

Net cash inflow from investing activities

(11)

28

28

Cash flows from financing activities

Proceeds of issuance of ordinary shares

198

-

-

Repayments of borrowings

(5)

(7)

(13)

Net cash outflow from financing

193

(7)

(13)

Net decrease in cash and cash equivalents

(140)

(602)

(1,238)

Cash and cash equivalents at beginning of period

553

1,791

1,791

Cash and cash equivalents at end of period

413

1,189

553

 CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (UNAUDITED)

Share capital 

£'000

Share premium 

£'000

Other reserve 

 £'000

Share based payment reserve

£'000

Accumul-ated losses 

£'000

Total

 

£'000

Balance as at 1 January 2008

378

10,114

630

77

(9,107)

2,092

Loss for the period

-

-

-

-

(674)

(674)

Share based payments

-

-

-

14

-

14

Balance as at 30 June 2008

378

10,114

630

91

(9,781)

1,432

Loss for the period

-

-

-

-

(667)

(667)

Share based payments

-

-

-

(26)

-

(26)

Balance as at 31 December 2008

378

10,114

630

65

(10,448)

739

Loss for the period

-

-

-

-

(457)

(457)

Share based payments

-

-

-

(11)

-

(11)

Shares issued in the period

200

(2)

-

-

-

198

Balance as at 30 June 2009

578

10,112

630

54

(10,905)

469

  NOTES TO THE FINANCIAL STATEMENTS

 

1. Basis of preparation

These interim financial statements have been prepared in accordance with the accounting policies set out in the Annual Report and Accounts for the year ended 31 December 2008 and the interpretation of those accounting standards underlying the accounting policies. IAS 34, Interim Financial Reporting, has not been applied. The interim financial statements have been issued in accordance with the AIM Rules of the London Stock Exchange and are unaudited. The financial information set out does not constitute statutory accounts for the purposes of section 240 of the Companies Act 1985. The auditors’ report on the statutory accounts for the year ended 31 December 2008 which have been filed with the Registrar of Companies was unqualified and does not contain a statement under Companies Act 1985 sections 237(2) or (3).

 

The preparation of financial statements requires estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Although the estimates are based on management's best knowledge of the amounts, events or actions, actual results may differ from those estimates.

The interim statements for the six months ended 30 June 2009 will be published on the company's website at www.ukplc.net. 

This announcement was approved by the board of @UK PLC on 11 August 2009.

2. Revenue (unaudited)

Set out below is an analysis of revenue recognised between principal product categories, which the Directors use to assess future revenue flows from customers.

Revenue 

months to

30 June

2009

£'000

months to

30 June

2008

£'000

Year ended

31 Dec

2008

£'000

Company formation services

616

627

1,262

Web and ecommerce services

610

451

910

1,226

1,078

2,172

3. Exceptional items (unaudited)

months to

30 June

2009

£'000

months to

30 June

2008

£'000

Year ended

31 Dec

2008

£'000

Reorganisation costs (see note below)

53

67

132

Provision for impairment of goodwill

-

-

96

53

67

228

Reorganisation costs represent the costs incurred in reducing staff numbers.

  

4. Loss per share (unaudited)

The calculations for loss per share are based on the weighted average number of shares in issue during the period 44,603,026 (6 months to 30 June 2008: 37,779,822; year ended 31 December 200837,779,822) and the following losses:

months to

30 June 2009

£'000

months to

30 June 2008

£'000

Year ended

31 Dec 2008

£'000

Unadjusted earnings:

Loss on ordinary activities after tax

( 457)

( 674)

(1,340)

Add back:

Exceptional reorganisation costs

53

67

228

Share based payments

(11)

14

(13)

Adjusted earnings:

(415)

(593)

(1,125)

The share options and warrants are not dilutive as they would not increase the loss per share in the year.

The basic and diluted loss per share calculated on the adjusted earnings is 0.9p (6 months to 30 June 20081.6p; year ended 31 December 2008: 3.0p).

5.  Post Balance Sheet Events

There are no post balance sheet events requiring disclosure.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR CKDKPABKDOFD
Date   Source Headline
5th Feb 20204:41 pmRNSSecond Price Monitoring Extn
5th Feb 20204:35 pmRNSPrice Monitoring Extension
31st Jan 20205:30 pmRNSCloudbuy
27th Jan 20202:09 pmRNSResult of General Meeting
24th Jan 20204:34 pmRNSHolding(s) in Company
24th Jan 20204:32 pmRNSHolding(s) in Company
10th Jan 20205:47 pmRNSDirector dealing
9th Jan 20209:12 amRNSProposed cancellation of AIM admission
7th Jan 20205:31 pmRNSFourth Interest Payment for New CLS
4th Nov 20192:00 pmRNSSeventh Interest Payment
28th Aug 20194:40 pmRNSHolding(s) in Company
21st Aug 20197:00 amRNSInterim Results
15th Jul 201910:36 amRNSHolding(s) in Company
11th Jul 20197:00 amRNSThird Interest Payment for New CLS
26th Apr 20197:00 amRNSSixth Interest Payment
16th Apr 20192:34 pmRNSResult of AGM
16th Apr 20197:00 amRNSAGM Statement
8th Apr 20197:00 amRNSDirector/PDMR Shareholding
28th Mar 20197:00 amRNSSale of Company Formations Business
26th Mar 20195:07 pmRNSHolding(s) in Company
20th Mar 20199:36 amRNSCorrection: Final Results
20th Mar 20197:00 amRNSFinal Results, Funding Update & Directorate Change
20th Feb 20198:06 amRNSHolding(s) in Company
8th Feb 20197:00 amRNSTrading Statement
5th Feb 20195:22 pmRNSHolding(s) in Company
4th Jan 20193:07 pmRNSSecond Interest Payment for New CLS
29th Oct 20184:40 pmRNSSecond Price Monitoring Extn
29th Oct 20184:35 pmRNSPrice Monitoring Extension
29th Oct 20187:00 amRNSFifth Interest Payment
24th Oct 201810:45 amRNSHolding(s) in Company
22nd Aug 20187:13 amRNSInterim Results
19th Jul 20187:00 amRNSFirst Interest Payment for New CLS
28th Jun 20187:00 amRNSDirector Dealing of Shares
30th May 20187:00 amRNSFourth Interest Payment
18th Apr 201811:08 amRNSResult of AGM
17th Apr 20187:00 amRNSAGM Statement
11th Apr 20187:00 amRNSTR-1: Notification of Major Interest in Shares
16th Mar 20187:10 amRNSFinal Results and Date of AGM
2nd Feb 20187:24 amRNSTR-1: Notification of Major Interest in Shares
24th Jan 20187:00 amRNSTrading Update
19th Jan 20185:20 pmRNSTR-1: Notification of Major Interest in Shares
27th Dec 20172:10 pmRNSResult of General Meeting
8th Dec 20177:00 amRNSIssue of up to £3.4m Convertible Loan Notes
30th Oct 20175:14 pmRNSTR-1: Notification of Major Interest in Shares
30th Oct 20175:08 pmRNSTR-1: Notification of Major Interest in Shares
30th Oct 20175:04 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
30th Oct 20177:00 amRNSThird Interest Payment
20th Sep 20177:00 amRNSDirector/PDMR Shareholding
16th Aug 201712:12 pmRNSInterim Results - Replacement
16th Aug 20177:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.